Equity Research, Broker Reports, and media content on ELI LILLY & CO

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ELI LILLY & CO
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ELI LILLY & CO. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
20Dec16 12:30 PRN Drug Makers Stocks under Scanner -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline
19Dec16 02:31 PRN Pricewatch Alert: Adobe Systems, Gulfport Energy, Eli Lilly, Coca-Cola, and Visa and more offer option-trading opportunities that offer returns of more than 20%
16Dec16 07:06 PRN Boehringer Ingelheim and Lilly Welcome New Recommendation for Jardiance® (empagliflozin) Tablets in Updated American Diabetes Association's 2017 Standards
16Dec16 12:48 PRN CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis (RA)
15Dec16 12:00 PRN BASAGLAR® (insulin glargine injection 100 units/mL), A Long-Acting Basal Insulin, Is Now Available in U.S.
15Dec16 11:25 PRN Lilly Provides 2017 Financial Guidance and 2016 Update, Reaffirms Financial Expectations Through the Remainder of the Decade
09Dec16 12:00 PRN Lilly and AstraZeneca to Develop Second Potentially Disease-Modifying Treatment for Alzheimer's Disease
  • Frequency of research reports

     

  • Research reports on

    ELI LILLY & CO

  • Providers covering

    ELI LILLY & CO